Julia Lewis, MD
Enriched profileProfessor of Medicine, Division of Nephrology and Hypertension · Vanderbilt University Medical Center
Julia Lewis is Professor of Medicine, Division of Nephrology and Hypertension at Vanderbilt University Medical Center. OpenAlex indexes 202 publications with 40,230 citations (h-index 60); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Julia Breyer Lewis, MD, is Professor of Medicine, Division of Nephrology and Hypertension at Vanderbilt University Medical Center. The public record shows 202 publications with 40,230 citations (h-index 60), centered on Chronic Kidney Disease and Diabetes, Blood Pressure and Hypertension Studies, Dialysis and Renal Disease Management. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 10 companies, 4 NIH-funded awards (1987–2008).
- Most recent indexed publication: 2026 · Circulation. Heart failure
- Top research focus: Chronic Kidney Disease and Diabetes
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 122.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Member/Chair
FDA Cardiovascular and Renal Drugs Advisory Committee, participates in FDA regulatory review of cardio-renal drug applications
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Pyridorin in Diabetic Nephropathy
Sponsor: NephroGenex, Inc.
- A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
Sponsor: Keryx Biopharmaceuticals
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
Sponsor: Keryx Biopharmaceuticals
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20253 payments$13,223openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year20253 payments
- Biogen, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
46.9%Angiotensin receptor blocker (ARB)11.9%Losartan Potassium100%Part D≥43 patientsCalcium channel blocker10.1%Nifedipine Er60%Amlodipine Besylate40%Part D≥21 patientsMetabolism & gastrointestinal
18.2%SGLT2 inhibitor5.3%Farxiga48%Jardiance32%Invokana20%Part D<11 patientsVitamin D3 Analog4%Calcitriol100%Part D≥16 patientsBlood & clotting
13.2%Solutions for parenteral nutrition13.2%Calcium Acetate100%Part D≥42 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 1987–2008 per NIH RePORTER. The latest:
- AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK) COHORT STUD
Vanderbilt University
FY2008$1,089M01RR000095 - AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK) COHORT STUD
Vanderbilt University
FY2007$23,124M01RR000095
Congress activity
Updated 27 Aug 2026
1 congress contribution (2022) across ADA per OpenAlex. The most recent:
- 864-P: Glycemic Control across eGFR Categories with the Dual SGLT1 and 2 Inhibitor Sotagliflozin in SCORED
ADA Scientific Sessions
ADA2022Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.
Circulation. Heart failure
Article2026 - Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.
Clinical journal of the American Society of Nephrology
Article2025 - Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.
Journal of the American Society of Nephrology
Article2024 - Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
Journal of the American Society of Nephrology
Article2024
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1,830 citations2020
- 04Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease1,176 citations2020
- 05Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy1,104 citations2008
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/julia-lewis-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- LinkedIn
LinkedIn: linkedin.com/in/julia-lewis-49b89b3b (listed as "prof of medicine, Vanderbilt University")
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wag.app.vanderbilt.edu ↗
- B.S.
University of Illinois at Urbana-Champaign
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wag.app.vanderbilt.edu ↗ - Board Certified
Internal Medicine and Nephrology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗
Editorial & leadership roles
journal and society appointments- Nephrology Fellowship Program Director
Vanderbilt University Medical Center (25+ years)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗ - Chair
FDA Cardiovascular and Renal Drugs Advisory Committee (Cardio-Renal Panel), second term
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗
Awards & honors
honors on the public record- "Top MD" recognition
Consumers' Checkbook
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- Vanderbilt O'Brien Kidney Center
affiliated faculty
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medsites.vumc.org ↗ - Collaborative Study Group (CSG)
Executive Committee member 20+ years, former president; coordinating center based at Vanderbilt
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center